We are live on ! Find out more
TLX

Telix Pharmaceuticals
TLX

40 hedge funds and large institutions have $8.47M invested in Telix Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 4

48% more funds holding

Funds holding: 27 → 40 (+13)

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

8% more capital invested

Capital invested by funds: $7.88M → $8.47M (+$591K)

0.09% more ownership

Funds ownership: 0.24% → 0.33% (+0.09%)

Holders
40
Holders Change
+13
Holders Change %
+48.15%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
11
Reduced
9
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PIC
Portland Investment Counsel
Ontario, Canada
+$1.33M
2
Lazard Asset Management
Lazard Asset Management
New York
+$1.31M
3
JP Morgan Chase
JP Morgan Chase
New York
+$472K
4
QC
Quadrature Capital
United Kingdom
+$354K
5
Mariner
Mariner
Kansas
+$352K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.7M
2
Jane Street
Jane Street
New York
-$317K
3
HF
HRT Financial
New York
-$111K
4
UBS Group
UBS Group
Switzerland
-$34.7K
5
Marshall Wace
Marshall Wace
United Kingdom
-$18.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
EWA
26
EverSource Wealth Advisors
Alabama
$6.73K +$7.44K +773 +618%
AP
27
Aspect Partners
Virginia
$2.64K +$3.39K +352 New
Osaic Holdings
28
Osaic Holdings
Arizona
$2.35K -$212 -22 -7%
BWA
29
Basecamp Wealth Advisors
Washington
$2.07K +$2.66K +276 New
BlackRock
30
BlackRock
New York
$659 +$847 +88 New
SAM
31
Smartleaf Asset Management
Massachusetts
$558 +$693 +72 New
IBOK
32
Independence Bank of Kentucky
Kentucky
$494 +$635 +66 New
CFM
33
Cornerstone Financial Management
Massachusetts
$382 +$491 +51 New
AssetMark Inc
34
AssetMark Inc
California
$337 +$38 +4 +10%
TFA
35
Transamerica Financial Advisors
Florida
$187 – – –
PA
36
Parallel Advisors
California
$93 +$115 +12 New
MCM
37
MV Capital Management
Maryland
$83 +$106 +11 New
FFA
38
Farther Finance Advisors
California
$67 – – –
TWD
39
True Wealth Design
Ohio
$23 – – –
SAG
40
SageView Advisory Group
California
$15 +$19 +2 New
HF
41
HRT Financial
New York
– -$111K -11,641 Closed
SOW
42
State of Wyoming
Wyoming
– -$12.4K -1,293 Closed
LFG
43
Larson Financial Group
Missouri
– -$507 -53 Closed
PS
44
Principal Securities
Iowa
– -$201 -21 Closed
1
2

TLX Hedge Fund Activity: Q4 2025 in Review

40 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in Telix Pharmaceuticals (TLX) for Q4 2025, worth a combined $8.47M — up 7.5% from $7.88M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new TLX positions and 4 closed out — a net gain of 13 holders — while 11 added to existing stakes and 9 trimmed.

The largest buyer was Portland Investment Counsel, adding an estimated $1.33M. The largest seller was Millennium Management, cutting an estimated $1.7M.

  • 40 institutional investors held Telix Pharmaceuticals (TLX) as of Q4 2025, up from 27 in Q3 2025.
  • Funds reported $8.47M of Telix Pharmaceuticals stock for Q4 2025, up 7.5% quarter-over-quarter.
  • 17 funds opened new Telix Pharmaceuticals positions in Q4 2025 and 4 closed out, a net change of +13 holders.
  • The largest Telix Pharmaceuticals buyer in Q4 2025 was Portland Investment Counsel, an estimated $1.33M added.
  • The largest Telix Pharmaceuticals seller in Q4 2025 was Millennium Management, an estimated $1.7M sold.

Based on aggregated 13F filings for Q4 2025.